CAS 2009_A_1820 Stefan Schumacher vs UCI

TAS 2009/A/1820 Stefan Schumacher c. Union Cycliste Internationale

CAS 2009/A/1820 Stefan Schumacher vs UCI

Related cases:

  • CAS 2009/A/2011 Stephan Schumacher vs IOC
    May 6, 2010
  • IOC 2009 IOC vs Stefan Schumacher
    November 18, 2009

In October 2008 the French Anti-Doping Agency (AFLD) has reported an anti-doping rule violation against the German cyclist Stefan Schumacher after his A and B samples tested positive for the prohibited substance methoxy polyethylene glycol-epoetin beta (CERA).

On 22 January 2009 the AFLD Disciplinary Panel imposed a 2 year period of ineligibility on the Athlete for a period of two years from all sports events organized by French sports federation. On 3 March 2009 the UCI issued a statement of international recognition of the decision rendered by the AFLD.

Hereafter in April 2009 Stefan Schumacher filed an appeal with the Court of Arbitration for Sport (CAS) in order to request the annulment of the UCI recognition statement.
In his defence the Athlete disputed the AFLD proceedings; the chain of custody; the competence and capability of the laboratory; and the validity of the test results.

Considering the Athlete’s objections the CAS Panel determines that the Athlete’s rights were not violated and that the valid test results showed the presence of the prohibited substance CERA in his samples.

Therefore on 22 January 2010 the Court of Arbitration for Sport decides to impose a 2 year period of ineligibility on the Athlete Stefan Schumacher, starting on 28 August 2008.

Original document

Parameters

Legal Source
CAS Appeal Awards
Date
22 January 2010
Arbitrator
Carrard, Olivier
Foucher, Bernard
Haas, Ulrich
Original Source
Court of Arbitration for Sport (CAS)
Country
Germany
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
International Standard for Laboratories (ISL)
Period of ineligibility
Privacy
Worldwide adoption of sanction
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Laboratories
Lausanne, Switzerland: Laboratoire Suisse d’Analyse du Dopage
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Analytical aspects
Accreditation of the testing laboratory
B sample analysis
Reliability of the testing method / testing result
Doping classes
S2. Peptide Hormones, Growth Factors
Substances
Erythropoietin (EPO)
Methoxy polyethylene glycol-epoetin beta (CERA)
Various
ADAMS
Chain of custody
Document type
Pdf file
Date generated
8 March 2012
Date of last modification
14 June 2023
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin